Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Dongyi Pharmaceutical is a comprehensive pharmaceutical enterprise based in Benxi, Liaoning Province, China, situated within the Benxi High-tech Industrial Development Zone. The company specializes in the research, development, production, and commercialization of chemical active pharmaceutical ingredients (APIs) and finished dosage forms, including tablets, capsules, and small-volume injections. Its product portfolio primarily targets therapeutic areas such as cardiovascular health, gastroenterology, and anti-infectives, with a focus on high-quality generic medications. Liaoning Dongyi operates modern manufacturing facilities that comply with Chinese Good Manufacturing Practice (GMP) standards, serving both domestic healthcare providers and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Dongyi Pharmaceutical.